D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 20,951 374 World Ranking 16821 National Ranking 8550

Overview

What is he best known for?

The fields of study Kristian Wachtell is best known for:

  • Diabetes mellitus
  • Blood pressure
  • Myocardial infarction

Part of his project on Confidence interval includes research on Hazard ratio and Quartile. In his works, Kristian Wachtell performs multidisciplinary study on Hazard ratio and Confidence interval. His research on Cardiology often connects related areas such as Muscle hypertrophy. Muscle hypertrophy connects with themes related to Cardiology in his study. In his articles, Kristian Wachtell combines various disciplines, including Blood pressure and Brachial artery. He connects Left ventricular hypertrophy with Electrocardiography in his research. Kristian Wachtell integrates many fields, such as Electrocardiography and Left ventricular hypertrophy, in his works. His Internal medicine study often links to related topics such as Diastole. He performs integrative study on Diastole and Blood pressure in his works.

His most cited work include:

  • Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy (54 citations)
  • Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study (49 citations)
  • Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study (46 citations)

What are the main themes of his work throughout his whole career to date

His study connects Microalbuminuria and Internal medicine. His Cardiology study frequently intersects with other fields, such as Vascular resistance. He integrates Blood pressure and Body mass index in his studies. In his articles, Kristian Wachtell combines various disciplines, including Body mass index and Blood pressure. In his papers, he integrates diverse fields, such as Left ventricular hypertrophy and Myocardial infarction. Kristian Wachtell performs integrative study on Myocardial infarction and Left ventricular hypertrophy. His Endocrinology study frequently draws connections between adjacent fields such as Muscle hypertrophy. His Muscle hypertrophy study frequently links to related topics such as Cardiology. His Angiotensin II study frequently draws connections to other fields, such as Losartan.

Kristian Wachtell most often published in these fields:

  • Internal medicine (100.00%)
  • Cardiology (96.43%)
  • Blood pressure (92.86%)

What were the highlights of his more recent work (between 2012-2022)?

  • Internal medicine (100.00%)
  • Blood pressure (100.00%)
  • Cardiology (100.00%)

In recent works Kristian Wachtell was focusing on the following fields of study:

Kristian Wachtell regularly links together related areas like Confidence interval in his Internal medicine studies. As part of his studies on Confidence interval, Kristian Wachtell often connects relevant subjects like Internal medicine. His multidisciplinary approach integrates Blood pressure and Left ventricular hypertrophy in his work. Kristian Wachtell combines Left ventricular hypertrophy and Blood pressure in his studies. His Cardiology study often links to related topics such as Muscle hypertrophy. His Muscle hypertrophy study frequently links to other fields, such as Cardiology. Kristian Wachtell integrates Heart failure and Ejection fraction in his studies. His work often combines Ejection fraction and Heart failure studies. His study in Clinical endpoint extends to Alternative medicine with its themes.

Between 2012 and 2022, his most popular works were:

  • Impact of overweight and obesity on cardiac benefit of antihypertensive treatment (27 citations)
  • A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers (19 citations)
  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (11 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Anne B. Rossebø;Terje R. Pedersen;Kurt Boman;Philippe Brudi.
The New England Journal of Medicine (2008)

1840 Citations

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen.
Journal of the American College of Cardiology (2005)

1119 Citations

Prognostic significance of left ventricular mass change during treatment of hypertension

Richard B Devereux;Kristian Wachtell;Eva Gerdts;Krister K. Boman.
JAMA (2004)

1067 Citations

Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study

Kristian Wachtell;Hans Ibsen;Michael H. Olsen;Knut Borch-Johnsen.
Annals of Internal Medicine (2003)

762 Citations

Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients. Losartan Intervention for Endpoint Reduction in Hypertension Study

Hans Ibsen;Michael H. Olsen;Kristian Wachtell;Knut Borch-Johnsen.
Hypertension (2005)

758 Citations

Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

Richard B. Devereux;Björn Dahlöf;Eva Gerdts;Kurt Boman.
Circulation (2004)

694 Citations

A Call to Action and a Lifecourse Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: The Lancet Commission on Hypertension

Michael H. Olsen;Michael H. Olsen;Sonia Y. Angell;Samira Asma;Pierre Boutouyrie.
The Lancet (2016)

634 Citations

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

Lars H. Lindholm;Hans Ibsen;Knut Borch-Johnsen;Michael Hecht Olsen.
Journal of Hypertension (2002)

547 Citations

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition: A Meta-Analysis

Markus P. Schneider;Tsushung A. Hua;Michael Böhm;Kristian Wachtell.
Journal of the American College of Cardiology (2010)

484 Citations

Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

Thomas Sehestedt;Jørgen Jeppesen;Tine W. Hansen;Kristian Wachtell.
European Heart Journal (2010)

440 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kristian Wachtell

Richard B. Devereux

Richard B. Devereux

Cornell University

Publications: 118

Sverre E. Kjeldsen

Sverre E. Kjeldsen

University of Oslo

Publications: 107

Giuseppe Mancia

Giuseppe Mancia

University of Milano-Bicocca

Publications: 107

Philippe Pibarot

Philippe Pibarot

Université Laval

Publications: 105

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 94

Giovanni de Simone

Giovanni de Simone

University of Naples Federico II

Publications: 83

Massimo Volpe

Massimo Volpe

Sapienza University of Rome

Publications: 78

Luis M. Ruilope

Luis M. Ruilope

European University of Madrid

Publications: 71

Guido Grassi

Guido Grassi

University of Milano-Bicocca

Publications: 65

Josep Redon

Josep Redon

University of Valencia

Publications: 60

Catherine M. Otto

Catherine M. Otto

University of Washington

Publications: 57

Alberto Zanchetti

Alberto Zanchetti

University of Milan

Publications: 56

Roland E. Schmieder

Roland E. Schmieder

University of Erlangen-Nuremberg

Publications: 55

Ramachandran S. Vasan

Ramachandran S. Vasan

Boston University

Publications: 55

Peter M. Okin

Peter M. Okin

Cornell University

Publications: 52

Björn Dahlöf

Björn Dahlöf

Sahlgrenska University Hospital

Publications: 51

Something went wrong. Please try again later.